Clinical Trial Update: Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update indicates that an extracorporeal shock wave lithotriptor is being evaluated for fragmenting nephrolithiasis (kidney stones).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Snippet

Sponsor: Advance Shockwave Technology GmbH | Conditions: Kidney Stones | Phase 3 | Status: UNKNOWN